A C-terminal glutamine recognition mechanism revealed by E3 ligase TRIM7 structures

Nat Chem Biol. 2022 Nov;18(11):1214-1223. doi: 10.1038/s41589-022-01128-x. Epub 2022 Aug 18.

Abstract

The E3 ligase TRIM7 has emerged as a critical player in viral infection and pathogenesis. However, the mechanism governing the TRIM7-substrate association remains to be defined. Here we report the crystal structures of TRIM7 in complex with 2C peptides of human enterovirus. Structure-guided studies reveal the C-terminal glutamine residue of 2C as the primary determinant for TRIM7 binding. Leveraged by this finding, we identify norovirus and SARS-CoV-2 proteins, and physiological proteins, as new TRIM7 substrates. Crystal structures of TRIM7 in complex with multiple peptides derived from SARS-CoV-2 proteins display the same glutamine-end recognition mode. Furthermore, TRIM7 could trigger the ubiquitination and degradation of these substrates, possibly representing a new Gln/C-degron pathway. Together, these findings unveil a common recognition mode by TRIM7, providing the foundation for further mechanistic characterization of antiviral and cellular functions of TRIM7.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antiviral Agents
  • COVID-19*
  • Glutamine / metabolism
  • Humans
  • SARS-CoV-2
  • Tripartite Motif Proteins / metabolism
  • Ubiquitin-Protein Ligases* / metabolism
  • Ubiquitination

Substances

  • Ubiquitin-Protein Ligases
  • Glutamine
  • Antiviral Agents
  • TRIM7 protein, human
  • Tripartite Motif Proteins